Differential roles of α6β2∗ and α4β2∗ neuronal nicotinic receptors in nicotine- and cocaine-conditioned reward in mice

Neuropsychopharmacology

Volumn 40, Issue 2, 2015, Pages 350-360

  Sanjakdar, Sarah S ^a   Maldoon, Pretal P ^a   Marks, Michael J ^b   Brunzell, Darlene H ^a   Maskos, Uwe ^c   McIntosh, J Michael ^d   Bowers, M Scott ^a,e   Damaj, M Imad ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c INSTITUT PASTEUR   (France)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA-CONOTOXIN MII; ALPHA6BETA2 NICOTINIC ACETYLCHOLINE RECEPTOR; COCAINE; CONOTOXIN; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; LITHIUM CHLORIDE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA4BETA2; NICOTINIC RECEPTOR BLOCKING AGENT;

ANIMAL; AVOIDANCE BEHAVIOR; C57BL MOUSE; COMPARATIVE STUDY; CONDITIONING; DOSE RESPONSE; DRUG EFFECTS; FOOD; KNOCKOUT MOUSE; MALE; METABOLISM; NERVE CELL; PHYSIOLOGY; REWARD; SPATIAL BEHAVIOR;

ANIMALS; AVOIDANCE LEARNING; COCAINE; CONDITIONING (PSYCHOLOGY); CONOTOXINS; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD; LITHIUM CHLORIDE; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; RECEPTORS, NICOTINIC; REWARD; SPATIAL BEHAVIOR;

EID: 84939890985     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.177     Document Type: Article

References (47)

1. Blokhina EA, Kashkin VA, Zvartau EE, Danysz W, Bespalov AY (2005). Effects of nicotinic and NMDA receptor channel blockers on intravenous cocaine and nicotine self-administration in mice. Eur Neuropsychopharmacol 15: 219-225.
2. Brunzell DH, Boschen KE, Hendrick ES, Beardsley PM, Mcintosh JM (2010). Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine. Neuropsychopharmacology 35: 665-673.
3. Budney AJ, Higgins ST, Hughes JR, Bickel WK (1993). Nicotine and caffeine use in cocaine-dependent individuals. Subst Abuse 5: 117-130.
4. Cahir E, Pillidge K, Drago J, Lawrence AJ (2011). The necessity of a4∗ nicotinic receptors in nicotine-driven behaviors: dissociation between reinforcing and motor effects of nicotine. Neuropsychopharmacology 36: 1505-1517.
5. Calabresi P, Lacey MG, North RA (1998). Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br J Pharmacol 98: 135-140.
6. Champtiaux N, Han ZY, Bessis A, Rossi FM, Zoli M, Marubio L et al (2002). Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice. J Neurosci 22: 1208-1217.
7. Champtiaux N, Kalivas PW, Bardo MT (2006). Contribution of dihydro-beta-erythroidine sensitive nicotinic acetylcholine receptors in the ventral tegmental area to cocaine-induced behavioral sensitization in rats. Behav Brain Res 168: 120-126.
8. Corrigall WA, Coen KM, Adamson KL (1994). Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653: 278-284.
9. Di Chiara G (1999). Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol 375: 13-30.
10. Drenan RM, Grady SR, Whiteaker P, McClure-Begley T, McKinney S, Miwa JM et al (2008). In vivo activation of midbrain dopamine neurons via sensitized, high-affinity a6 nicotinic acetylcholine receptors. Neuron 60: 123-136.
11. Drenan RM, Grady SR, Steele AD, Mckinney S, Patzlaff NE, Mcintosh JM et al (2010). Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4∗ nicotinic acetylcholine receptors. J Neurosci 30: 9877-9889.
12. Exley R, Clements MA, Hartung H, Mcintosh JM, Cragg SJ, Exley R et al (2008). Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. Neuropsychopharmacology 33: 2158-2166.
13. Exley R, Maubourguet N, David V, Eddine R, Evrard A, Pons S et al (2011). Distinct contributions of nicotinic acetylcholine receptor subunit alpha4 and subunit alpha6 to the reinforcing effects of nicotine. Proc Natl Acad Sci USA 108: 7577-7582.
14. Fiserová M, Consolo S, Krsiak M, Fiserová M, Consolo S, Krsiak M (1999). Chronic morphine induces long-lasting changes in acetylcholine release in rat nucleus accumbens core and shell: an in vivo microdialysis study. Psychopharmacology 142: 85-94.
15. Gotti C, Guiducci S, Tedesco V, Corbioli S, Zanetti L, Moretti M et al (2010). Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2∗ receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. J Neurosci 30: 5311-5325.
16. Grady SR, Salminen O, Laverty DC, Whiteaker P, McIntosh JM, Collins AC et al (2007). The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochem Pharmacol 74: 1235-1246.
17. Grady SR, Murphy KL, Cao J, Marks MJ, McIntosh JM, Collins AC (2002). Characterization of nicotinic agonist-induced [3H] dopamine release from synaptosomes prepared from four mouse brain regions. J Pharmacol Exp Ther 301: 651-660.
18. Horger B, Giles M, Schenk S, Horger B, Giles A, Schenk M et al (1992). Preexposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine. Psychopharmacology 107: 271-276.
19. Jackson KJ, Marks MJ, Vann RE, Chen X, Gamage TF, Warner JA et al (2010). Role of alpha5 nicotinic acetylcholinereceptors in pharmacological and behavioral effects of nicotine in mice. J Pharmacol Exp Ther 334: 137-146.
20. Jackson KJ, McIntosh JM, Brunzell DH, Sanjakdar SS, Damaj MI (2009). The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal. J Pharmacol Exp Ther 331: 547.
21. Kalivas PW (2007). Neurobiology of cocaine addiction: implications for new pharmacotherapy. Am J Addict 16: 71-78.
22. Klink R, d'Exaerde A, Zoli M, Changeux JP (2001). Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci 21: 1452-1463.
23. Kota D, Martin BR, Robinson SE, Damaj MI (2007). Nicotine dependence and reward differ between adolescent and adult male mice. J Pharmacol Exp Ther 322: 399-407.
24. Lanca AJ, Adamson KL, Coen KM, Chow BL, Corrigall WA (2000). The pedunculopontine tegmental nucleus and the role of cholinergic neurons in nicotine self-administration in the rat: a correlative neuroanatomical and behavioral study. Neuroscience 96: 735-742.
25. Levin ED, Mead T, Rezvani AH, Rose JE, Gallivan C, Gross R (2000). The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats. Physiol Behav 71: 565-570.
26. Levine A, Huang Y, Drisaldi B, EAJr Griffin, Pollak DD, Xu S et al (2011). Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine. Sci Transl Med 3: 107-a109.
27. Marubio LM, Gardier AM, Durier S, David D, Klink R, Arroyo-Jimenez M et al (2003). Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. Eur J Neurosci 17: 1329-1337.
28. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux J et al (2005). Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436: 103-107.
29. Matsuo N, Takao K, Nakanishi K, Yamasaki N, Tanda K, Miyakawa T (2010). Behavioral profiles of three C57BL/6 substrains. Front Behav Neurosci 4: 29.
30. McGranahan TM, Patzlaff NE, Grady SR, Heinemann SF, Booker TK (2011). a4b2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief. J Neurosci 31: 10891-10902.
31. McIntosh JM, Azam L, Staheli S, Dowell C, Lindstrom JM, Kuryatov A et al (2004). Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors. Mol Pharmacol 65: 944-952.
32. Mekada K, Abe K, Murakami A, Nakamura S, Nakata H, Moriwaki K et al (2009). Genetic differences among C57BL/6 substrains. Exp Anim 58: 141-149.
33. Mulligan MK, Ponomarev I, Boehm SL 2nd, Owen JA, Levin PS, Berman AE et al (2008). Alcohol trait and transcriptional genomic analysis of C57BL/6 substrains. Genes Brain Behav 7: 677-689.
34. Nestby P, Vanderschuren Louk JMJ, De Vries TJ, Hogenboom F, Wardeh G, Mulder AH et al (1997). Ethanol, like psychostimulants and morphine, causes long-lasting hyperreactivity of dopamine and acetylcholine neurons of rat nucleus accumbens: possible role in behavioural sensitization. Psychopharmacology 133: 69-76.
35. Picciotto MR, Zoli M, Rimondini R, Léna C, Marubio LM, Pich EM et al (1998). Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391: 173-177.
36. Pons S, Fattore L, Cossu G, Tolu S, Porcu E, McIntosh JM et al (2008). Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci 28: 12318-12327.
37. Reid MS, Mickalian JD, Delucchi KL, Hall SM, Berger SP (1998). An acute dose of nicotine enhances cue-induced cocaine craving. Drug Alcohol Depend 49: 95-104.
38. Reid MS, Mickalian JD, Delucchi KL, Berger SP (1999). A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects. Neuropsychopharmacology 20: 297-307.
39. Ross SA, Wong JY, Clifford JJ, Kinsella A, Massalas JS, Horne MK et al (2000). Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. J Neurosci 20: 6431-6441.
40. Salminen O, Drapeau JA, Mcintosh JM, Collins AC, Marks MJ, Grady SR (2007). Pharmacology of alpha-conotoxin MIIsensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice. Mol Pharmacol 71: 1563-1571.
41. Sees KL, Clark HW (1993). When to begin smoking cessation in substance abusers. J Subst Abuse Treat 10: 189-195.
42. Tapper AR, Mckinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C et al (2004). Nicotine activation of alpha4∗ receptors: sufficient for reward, tolerance, and sensitization. Science 306: 1029-1032.
43. Walters CL, Brown S, Changeux JP, Martin B, Damaj MI (2006). The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl) 184: 339-344.
44. Whiteaker PM, McIntosh JM, Luo S, Collins AC, Marks MJ (2000). 125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. Mol Pharmacol 57: 913-925.
45. Zachariou V, Caldarone BJ, Weathers-Lowin A, George TP, Elsworth JD, Roth RH et al (2001). Nicotine receptor inactivation decreases sensitivity to cocaine. Neuropsychopharmacology 24: 576-589.
46. Zanetti L, Picciotto M, Zoli M (2007). Differential effects of nicotinic antagonists perfused into the nucleus accumbens or the ventral tegmental area on cocaine-induced dopamine release in the nucleus accumbens of mice. Psychopharmacology 190: 189-199.
47. Zoli M, Moretti M, Zanardi A, Mcintos JM, Clementi F, Gotti C (2002). Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci 22: 8785-8789.